Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.2031
Delayed Data
As of May 21
 -0.0124 / -5.75%
Today’s Change
0.14
Today|||52-Week Range
0.40
-13.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$87.1M

Company Description

Northwest Biotherapeutics, Inc. is a clinical stage biotechnology company. The firm engages in the development of cancer vaccines designed to treat solid tumor cancers. It also offers a platform technology for DCVax dendritic cell-based vaccines. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.

Contact Information

Northwest Biotherapeutics, Inc.
4800 Montgomery Lane
Bethesda Maryland 20814
P:(240) 497-9024
Investor Relations:

Employees

Shareholders

Mutual fund holders6.28%
Other institutional3.51%
Individual stakeholders12.90%

Top Executives

Linda F. PowersChairman, President & Chief Executive Officer
Alton L. BoyntonSecretary, Director & Chief Scientific Officer
Marnix L. BoschChief Technical Officer
Anthony E. MaidaSenior Vice President-Clinical Research
Leslie J. GoldmanSenior Vice President-Business Development